Enzymes for anti-infective therapy: Phage lysins

Drug Discovery Today: Therapeutic Strategies

Volumn 1, Issue 4, 2004, Pages 469-474

  López, Rubens ^a   García, Ernesto ^a   García, Pedro ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; HYDROLASE; LYSOZYME; XENOBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS ANTHRACIS; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ISOLATION; CELL WALL; DISEASE SEVERITY; LYSIS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; STREPTOCOCCUS GROUP A; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SURVIVAL;

EID: 13344261326     PISSN: 17406773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddstr.2004.09.002     Document Type: Review

References (28)

1. W.C. Summers Félix D'Herelle and the Origins of Molecular Biology 1999 Yale University Press
2. A. Sulakvelidze et al. Bacteriophage therapy Antimicrob. Agents Chemother. 45 2001 149-659
3. P.L. Wagner M.K. Waldor Bacteriophage control of bacterial virulence Infect. Immun. 70 2002 3985-3993
4. W.C. Summers Bacteriophage therapy Annu. Rev. Microbiol. 55 2001 437-451
5. N. Mushtaq et al. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype Antimicrob. Agents Chemother. 48 2004 1503-1508
6. B.R. Levin J.J. Bull Population and evolutionary dynamics of phage therapy Nat. Microbiol. Rev. 2 2004 166-173
7. J. Liu et al. Antimicrobial drug discovery through bacteriophage genomics Nat. Biotechnol. 22 2004 185-191
8. S. Hagens U. Bläsi Genetically modified filamentous phage as bactericidal agents: A pilot study Lett. Appl. Microbiol. 37 2003 318-323
9. M. McDonnell et al. "Diplophage": A bacteriophage of Diplococcus pneumoniae Virology 63 1975 577-582
10. C. Ronda et al. Isolation and characterization of a new bacteriophage, Cp-1, infecting Streptococcus pneumoniae J. Virol. 40 1981 551-559
11. P. García et al. Bacteriophages of Streptococcus pneumoniae: A molecular approach (A. Tomasz, ed.) Streptococcus pneumoniae - Molecular Biology & Mechanisms of Disease 2000 Mary Ann Liebert, Inc 211-222
12. R. López et al. Cell wall murein hydrolases (E.I. Tuomanen T.J. Mitchell D. Morrison B.G. Spratt ed.). In: The Pneumococcus 2004 ASM Press 75-88
13. C. Fernández-Tornero et al. A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA Nat. Struct. Biol. 8 2001 1020-1024
14. P. García et al. Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages Gene 86 1990 81-88
15. J.A. Hermoso et al. Structural basis for selective recognition of the pneumococcal cell wall by modular endolysin from phage Cp-1 Structure 11 2003 1239-1249
16. D. Nelson et al. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme Proc. Natl. Acad. Sci. USA 98 2001 4107-4112
17. J.M. Loeffler et al. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase Science 294 2001 2170-2172
18. R. Schuch et al. A bacteriolytic agent that detects and kills Bacillus anthracis Nature 418 2002 884-889
19. I. Jado et al. Phage lytic enzymes as therapy of antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model J. Antimicrob. Chemother. 52 2003 967-973
20. J.M. Loeffler V.A. Fischetti Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains Antimicrob. Agents Chemother. 47 2003 375-377
21. J.M. Loeffler et al. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia Infect. Immun. 71 2003 6199-6204
22. E. Díaz et al. Chimeric phage-bacterial enzymes: A clue to the modular evolution of genes Proc. Natl. Acad. Sci. USA 87 1990 8125-8129
23. E. Díaz et al. Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits J. Biol. Chem. 266 1991 5464-5471
24. J.M. Sanz et al. Construction of a multifunctional pneumococcal murein hydrolase by module assembly Eur. J. Biochem. 235 1996 601-605
25. C. Croux et al. Interchange of functional domains switches enzyme specificity: Construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme Mol. Microbiol. 9 1993 1019-1025
26. P. Yoong et al. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium J. Bacteriol. 186 2004 4808-4812
27. R.M. Carlton et al. Phage therapy: Past history and future prospects Arch. Immunol. Ther. Exp. 47 1999 267-274
28. Larkin M. 2004 Vincent Fischetti-following phages for life. The Lancet Infect. Dis. 4, 246-249